Fig. 2.
Progression-free survival (PFS) (A) and overall survival (OS) (B) with second-line chemotherapy after progression on nab-paclitaxel plus gemcitabine (nab-P+GEM). 2L, second-line; CI, confidence interval.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.